Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 4465 record(s)

Req # A-2019-001718

Adverse Reaction Report (AER) for Dexedrine. Report number: E2B_02738940. AER for pdp-Hydrocodone. Report number: 726402.

Organization: Health Canada

11 page(s)
March 2020

Req # A-2019-001724

Adverse Reaction Report (AER) for Mesalazine. Report numbers: E2B_02700969, 000728070, 000728071, 000728455, 000728458, E2B_02661335, E2B_02674355, 000729330, 000729337, 000729356, 000729421, 000729425.

Organization: Health Canada

88 page(s)
March 2020

Req # A-2019-001752

Adverse Reaction Report (AER) for DOCUSATE SODIUM. Report numbers: 725417, E2B_02430183, E2B_02432728.

Organization: Health Canada

29 page(s)
March 2020

Req # A-2019-001817

Adverse Reaction Report (AER). Report number: E2B_02660917.

Organization: Health Canada

12 page(s)
March 2020

Req # A-2019-001821

Adverse Reaction Report (AER). Report number: E2B_02729931.

Organization: Health Canada

87 page(s)
March 2020

Req # A-2019-001831

Adverse Reaction Report (AER) for BUDESONIDE. Report number: 000706496. AER for PEPCID. Report numbers: 000073476, 000306801. AER for SUDAFED. Report numbers: 000002935, 000023107, 000038398, 000047309, 000047815, 000056579, 000060884, 000068759, 000078903, 000131813, 000143506, 000162185, 000169262, 000191398, 000338971, 000587580, E2B_02578758. AER for SINUTAB. Report number: 000137555. AER for COMBANTRIN. Report number: 000003051.

Organization: Health Canada

63 page(s)
March 2020

Req # A-2019-001843

Adverse Reaction Report (AER). Report number: 000730427.

Organization: Health Canada

2 page(s)
March 2020

Req # A-2019-001907

Adverse Reaction Report (AER) for NICORETTE. Report numbers: 000027272, 000064973, 000164524, 000220991, 000348446, 000348460, 000379862, 000397843, 000405318, 000442351, 000468242, 000478230, 000586046, 000684802, 000687080, 000704470, 000704826 AER for VISINE. Report numbers: 000047729, 000189286, 000189298 AER for AVEENO. Report number: 000697846. AER for NEUTROGENA. Report number: 000697771 AER for CLEAN & CLEAR. Report number: 000706860 AER for LISTERINE. Report numbers: 000452814, E2B_02379059.

Organization: Health Canada

70 page(s)
March 2020

Req # A-2019-001913

Adverse Reaction Report (AER). Report number: E2B_02700160.

Organization: Health Canada

316 page(s)
March 2020

Req # A-2019-001927

Adverse Reaction Report (AER) for Cuvitru. Report number: 000732250.

Organization: Health Canada

1 page(s)
March 2020
Date modified: